vs
Side-by-side financial comparison of Brookfield Renewable Partners L.P. (BEP) and Celanese Corp (CE). Click either name above to swap in a different company.
Celanese Corp is the larger business by last-quarter revenue ($2.2B vs $1.7B, roughly 1.3× Brookfield Renewable Partners L.P.). Brookfield Renewable Partners L.P. runs the higher net margin — 5.9% vs 0.6%, a 5.3% gap on every dollar of revenue. On growth, Brookfield Renewable Partners L.P. posted the faster year-over-year revenue change (14.2% vs -7.0%).
Brookfield Renewable Partners L.P.BEPEarnings & Financial Report
Brookfield Renewable Partners L.P. is a publicly traded limited partnership that owns and operates renewable power assets, with corporate headquarters in Toronto, Ontario, Canada. It is 60% owned by Brookfield Asset Management.
Celanese Corporation, formerly known as Hoechst Celanese, is an American technology and specialty materials company headquartered in Irving, Texas. It is a Fortune 500 corporation. The company is the world's leading producer of acetic acid, producing about 1.95 million tonnes per year, representing approximately 20% of global production. Celanese is also the world's largest producer of vinyl acetate monomer (VAM).
BEP vs CE — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $2.2B |
| Net Profit | $100.0M | $14.0M |
| Gross Margin | — | 19.1% |
| Operating Margin | — | 4.0% |
| Net Margin | 5.9% | 0.6% |
| Revenue YoY | 14.2% | -7.0% |
| Net Profit YoY | 213.6% | 100.7% |
| EPS (diluted) | $-0.22 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | $1.7B | $2.5B | ||
| Q1 25 | — | $2.4B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | $1.5B | $2.7B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | — | $14.0M | ||
| Q3 25 | — | $-1.4B | ||
| Q2 25 | $100.0M | $199.0M | ||
| Q1 25 | — | $-21.0M | ||
| Q4 24 | — | $-1.9B | ||
| Q3 24 | — | $116.0M | ||
| Q2 24 | $-88.0M | $155.0M | ||
| Q1 24 | — | $121.0M |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 21.5% | ||
| Q2 25 | — | 21.1% | ||
| Q1 25 | — | 19.9% | ||
| Q4 24 | — | 22.7% | ||
| Q3 24 | — | 23.5% | ||
| Q2 24 | — | 24.2% | ||
| Q1 24 | — | 21.2% |
| Q4 25 | — | 4.0% | ||
| Q3 25 | — | -52.7% | ||
| Q2 25 | — | 9.2% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | -59.3% | ||
| Q3 24 | — | 9.4% | ||
| Q2 24 | — | 9.4% | ||
| Q1 24 | — | 8.0% |
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | -56.1% | ||
| Q2 25 | 5.9% | 7.9% | ||
| Q1 25 | — | -0.9% | ||
| Q4 24 | — | -80.8% | ||
| Q3 24 | — | 4.4% | ||
| Q2 24 | -5.9% | 5.8% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | — | $0.13 | ||
| Q3 25 | — | $-12.39 | ||
| Q2 25 | $-0.22 | $1.81 | ||
| Q1 25 | — | $-0.19 | ||
| Q4 24 | — | $-17.50 | ||
| Q3 24 | — | $1.06 | ||
| Q2 24 | $-0.28 | $1.41 | ||
| Q1 24 | — | $1.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | — |
| Total DebtLower is stronger | — | $11.4B |
| Stockholders' EquityBook value | $33.3B | $4.0B |
| Total Assets | $98.6B | $21.7B |
| Debt / EquityLower = less leverage | — | 2.81× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $11.4B | ||
| Q3 25 | — | $11.7B | ||
| Q2 25 | — | $12.7B | ||
| Q1 25 | — | $12.4B | ||
| Q4 24 | — | $11.1B | ||
| Q3 24 | — | $11.3B | ||
| Q2 24 | — | $11.1B | ||
| Q1 24 | — | $11.0B |
| Q4 25 | — | $4.0B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | $33.3B | $5.3B | ||
| Q1 25 | — | $5.2B | ||
| Q4 24 | — | $5.2B | ||
| Q3 24 | — | $7.3B | ||
| Q2 24 | $28.0B | $7.2B | ||
| Q1 24 | — | $7.1B |
| Q4 25 | — | $21.7B | ||
| Q3 25 | — | $22.2B | ||
| Q2 25 | $98.6B | $23.7B | ||
| Q1 25 | — | $23.2B | ||
| Q4 24 | — | $22.9B | ||
| Q3 24 | — | $25.9B | ||
| Q2 24 | $73.8B | $25.8B | ||
| Q1 24 | — | $26.0B |
| Q4 25 | — | 2.81× | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 2.39× | ||
| Q4 24 | — | 2.14× | ||
| Q3 24 | — | 1.56× | ||
| Q2 24 | — | 1.54× | ||
| Q1 24 | — | 1.56× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $379.0M | $252.0M |
| Free Cash FlowOCF − Capex | — | $168.0M |
| FCF MarginFCF / Revenue | — | 7.6% |
| Capex IntensityCapex / Revenue | — | 3.8% |
| Cash ConversionOCF / Net Profit | 3.79× | 18.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $803.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $252.0M | ||
| Q3 25 | — | $447.0M | ||
| Q2 25 | $379.0M | $410.0M | ||
| Q1 25 | — | $37.0M | ||
| Q4 24 | — | $494.0M | ||
| Q3 24 | — | $79.0M | ||
| Q2 24 | $231.0M | $292.0M | ||
| Q1 24 | — | $101.0M |
| Q4 25 | — | $168.0M | ||
| Q3 25 | — | $383.0M | ||
| Q2 25 | — | $317.0M | ||
| Q1 25 | — | $-65.0M | ||
| Q4 24 | — | $389.0M | ||
| Q3 24 | — | $-9.0M | ||
| Q2 24 | — | $187.0M | ||
| Q1 24 | — | $-36.0M |
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 15.8% | ||
| Q2 25 | — | 12.5% | ||
| Q1 25 | — | -2.7% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | — | -0.3% | ||
| Q2 24 | — | 7.1% | ||
| Q1 24 | — | -1.4% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 5.2% |
| Q4 25 | — | 18.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.79× | 2.06× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 1.88× | ||
| Q1 24 | — | 0.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BEP
Segment breakdown not available.
CE
| Engineered Materials | $1.3B | 58% |
| Acetyl Chain | $940.0M | 43% |
